0000899243-20-034885.txt : 20201222 0000899243-20-034885.hdr.sgml : 20201222 20201222192912 ACCESSION NUMBER: 0000899243-20-034885 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201218 FILED AS OF DATE: 20201222 DATE AS OF CHANGE: 20201222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gilde Healthcare Holding B.V. CENTRAL INDEX KEY: 0001420106 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39293 FILM NUMBER: 201409437 BUSINESS ADDRESS: STREET 1: NEWTONLAAN 91 STREET 2: PO BOX 85067 CITY: 3508 UTRECHT STATE: P7 ZIP: AB BUSINESS PHONE: 31(0)30-2192549 MAIL ADDRESS: STREET 1: NEWTONLAAN 91 STREET 2: PO BOX 85067 CITY: 3508 UTRECHT STATE: P7 ZIP: AB REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gilde Healthcare IV Management B.V. CENTRAL INDEX KEY: 0001757508 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39293 FILM NUMBER: 201409438 BUSINESS ADDRESS: STREET 1: NEWTONLAAN 91 CITY: UTRECHT STATE: P7 ZIP: 3584 BP BUSINESS PHONE: 949-396-6322 MAIL ADDRESS: STREET 1: NEWTONLAAN 91 CITY: UTRECHT STATE: P7 ZIP: 3584 BP REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cooperatieve Gilde Healthcare IV U.A. CENTRAL INDEX KEY: 0001756335 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39293 FILM NUMBER: 201409439 BUSINESS ADDRESS: STREET 1: NEWTONLANN 51 CITY: UTRECHT STATE: P7 ZIP: 3508AB BUSINESS PHONE: 949-396-6322 MAIL ADDRESS: STREET 1: NEWTONLANN 51 CITY: UTRECHT STATE: P7 ZIP: 3508AB ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inari Medical, Inc. CENTRAL INDEX KEY: 0001531048 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 452902923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 PARKER, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-923-4747 MAIL ADDRESS: STREET 1: 9 PARKER, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: Inceptus Newco1 Inc. DATE OF NAME CHANGE: 20110923 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-18 0 0001531048 Inari Medical, Inc. NARI 0001756335 Cooperatieve Gilde Healthcare IV U.A. NEWTONLAAN 91 3584 BP UTRECHT P7 NETHERLANDS 0 0 1 0 0001757508 Gilde Healthcare IV Management B.V. NEWTONLAAN 91 3584 BP UTRECHT P7 NETHERLANDS 0 0 1 0 0001420106 Gilde Healthcare Holding B.V. NEWTONLAAN 91 3584 BP UTRECHT P7 NETHERLANDS 0 0 1 0 Common Stock 2020-12-18 4 S 0 63840 70.52 D 6877839 I See footnote Common Stock 2020-12-18 4 S 0 110474 71.53 D 6767365 I See footnote Common Stock 2020-12-18 4 S 0 41878 72.16 D 6725487 I See footnote Common Stock 2020-12-21 4 S 0 11885 70.41 D 6713602 I See footnote Common Stock 2020-12-21 4 S 0 13125 71.73 D 6700477 I See footnote Common Stock 2020-12-21 4 S 0 54257 72.47 D 6646220 I See footnote Common Stock 2020-12-21 4 S 0 71415 73.47 D 6574805 I See footnote Common Stock 2020-12-21 4 S 0 44268 74.53 D 6530537 I See footnote Common Stock 2020-12-22 4 S 0 20754 76.11 D 6509783 I See footnote Common Stock 2020-12-22 4 S 0 71340 77.22 D 6438443 I See footnote Common Stock 2020-12-22 4 S 0 98190 78.21 D 6340253 I See footnote Common Stock 2020-12-22 4 S 0 4880 78.57 D 6335373 I See footnote Common Stock 2020-12-22 4 S 0 4714 74.48 D 6330659 I See footnote Common Stock 2020-12-22 4 S 0 5287 76.12 D 6325372 I See footnote Common Stock 2020-12-22 4 S 0 43841 77.22 D 6281531 I See footnote Common Stock 2020-12-22 4 S 0 6316 77.79 D 6275215 I See footnote Common Stock 2020-12-22 4 S 0 28700 78.31 D 6246515 I See footnote The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.995 inclusive. The Reporting Persons undertake to provide to Inari Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $71.00 to $71.995, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $72.00 to $72.435, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.885, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $71.00 to $71.995, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $72.00 to $72.995, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $73.00 to $73.99, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $74.00 to $74.795, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $75.605 to $76.59, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $76.605 to $77.60, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $77.605 to $78.50, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $78.51 to $78.68, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $74.09 to $74.71, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $75.645 to $76.625, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $76.6675 to $77.665, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $77.67 to $77.995, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $78.00 to $78.81, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Cooperatieve Gilde Healthcare IV U.A., By: /s/ Marc Perret, Name: Marc Perret, Title: Managing Director 2020-12-22 Gilde Healthcare IV Management B.V., By: /s/ Marc Perret, Name: Marc Perret, Title: Managing Director 2020-12-22 Gilde Healthcare Holding B.V., By: /s/ Marc Perret, Name: Marc Perret, Title: Managing Director 2020-12-22